Sign up
Quantellect · Congress · Trade Detail
NASDAQ: REGNRegeneron Pharmaceuticals Inc
RepublicanHouse

Robert P. Bresnahan, Jr. bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Robert P. Bresnahan, Jr. (R-PA), a U.S. Representative, has disclosed 3 trades in Regeneron Pharmaceuticals Inc (REGN) since 2025, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Robert P. Bresnahan, Jr. bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on May 15, 2025. Since that trade, REGN is up +19.71% against the S&P 500 up +24.96%, an outperformance of -5.25%.

Across these filings, Robert P. Bresnahan, Jr. has been a net seller of REGN (a buy-to-sell ratio of 0.50). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

REGN trades
3
Disclosed Vol
$24K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2025

Robert P. Bresnahan, Jr.'s REGN trades vs the price

REGN is up +19.71% since Robert P. Bresnahan, Jr. bought on May 15, 2025, versus +24.96% for the S&P 500.

Performance since this trade

Price change since trade
+19.71%
S&P 500 change since trade
+24.96%
Outperformance vs S&P 500
-5.25%

All Robert P. Bresnahan, Jr. REGN trades

TradedTypeSizeReturnEst. profit
May 15, 2025BUY$580.94+19.71%+$2K
April 8, 2025SELL$552.96+25.76%
February 25, 2025SELL$718.47-3.21%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Robert P. Bresnahan, Jr. & REGN trading FAQ

Is it legal for Robert P. Bresnahan, Jr. to trade Regeneron Pharmaceuticals Inc (REGN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Robert P. Bresnahan, Jr. buy REGN?

Robert P. Bresnahan, Jr. disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on May 15, 2025, according to public STOCK Act filings.

How has REGN performed since Robert P. Bresnahan, Jr.'s trade?

Since Robert P. Bresnahan, Jr. bought REGN on May 15, 2025, the stock is up +19.71%, versus +24.96% for the S&P 500 over the same period, an outperformance of -5.25%.

How many times has Robert P. Bresnahan, Jr. traded REGN?

Robert P. Bresnahan, Jr. has disclosed 3 REGN trades since 2025 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional REGN trades?

Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Robert P. Bresnahan, Jr.'s REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncRobert P. Bresnahan, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.